DE60134791D1 - Signal-1/signal-2-bifunktionelle peptidinhibitoren - Google Patents

Signal-1/signal-2-bifunktionelle peptidinhibitoren

Info

Publication number
DE60134791D1
DE60134791D1 DE60134791T DE60134791T DE60134791D1 DE 60134791 D1 DE60134791 D1 DE 60134791D1 DE 60134791 T DE60134791 T DE 60134791T DE 60134791 T DE60134791 T DE 60134791T DE 60134791 D1 DE60134791 D1 DE 60134791D1
Authority
DE
Germany
Prior art keywords
chain
signal
moiety
immune response
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60134791T
Other languages
German (de)
English (en)
Inventor
Joseph S Murray
Teruna J Siahaan
Yongbo Hu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kansas
Original Assignee
University of Kansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Kansas filed Critical University of Kansas
Application granted granted Critical
Publication of DE60134791D1 publication Critical patent/DE60134791D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60134791T 2000-12-18 2001-12-17 Signal-1/signal-2-bifunktionelle peptidinhibitoren Expired - Fee Related DE60134791D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/739,466 US7786257B2 (en) 2000-12-18 2000-12-18 Signal-1/signal-2 bifunctional peptide inhibitors
PCT/US2001/048632 WO2002050250A2 (en) 2000-12-18 2001-12-17 Signal-1/signal-2 bifunctional peptide inhibitors

Publications (1)

Publication Number Publication Date
DE60134791D1 true DE60134791D1 (de) 2008-08-21

Family

ID=24972431

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60134791T Expired - Fee Related DE60134791D1 (de) 2000-12-18 2001-12-17 Signal-1/signal-2-bifunktionelle peptidinhibitoren

Country Status (8)

Country Link
US (1) US7786257B2 (enExample)
EP (2) EP1932539A3 (enExample)
JP (1) JP2004536783A (enExample)
AT (1) ATE400293T1 (enExample)
AU (1) AU2002230911A1 (enExample)
CA (1) CA2432767A1 (enExample)
DE (1) DE60134791D1 (enExample)
WO (1) WO2002050250A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8188218B2 (en) 2006-10-27 2012-05-29 University Of Kansas Bi-functional peptides for multiple sclerosis treatment and diagnosis
US8735154B2 (en) 2006-10-30 2014-05-27 The University Of Kansas Templated islet cells and small islet cell clusters for diabetes treatment
US8016856B2 (en) * 2006-11-30 2011-09-13 Cook Medical Technologies Llc Removable handle for medical device
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
EA023303B1 (ru) 2007-08-15 2016-05-31 Сиркейшиа Лимитед Пептидная композиция для формирования толерантности к клещам домашней пыли и ее применение
WO2009055054A2 (en) * 2007-10-25 2009-04-30 Janda Kim D Antibody-mediated disruption of quorum sensing in bacteria
DE102009040716B4 (de) * 2009-09-10 2011-07-14 Miltenyi Biotec GmbH, 51429 Verwendung von CD154 zur Identifizierung und Abtrennung von nicht-regulatorischen T-Zellen aus einem Gemisch mit regulatorischen T-Zellen
WO2011163568A1 (en) 2010-06-24 2011-12-29 University Of Kansas Conjugates comprising an n-oxime bond and associated methods
EP3498300A1 (en) 2011-07-27 2019-06-19 University of Kansas Templated islet cells and small islet cell clusters for diabetes treatment
CN105708834A (zh) * 2011-10-18 2016-06-29 株式会社爱茉莉太平洋 包含丁香脂素的sirt1活化剂
US11919939B2 (en) * 2017-05-23 2024-03-05 Université De Genève Beta-2-glycoprotein 1 derived peptide and use thereof for treating antiphospholipid syndrome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844095A (en) * 1991-06-27 1998-12-01 Bristol-Myers Squibb Company CTLA4 Ig fusion proteins
DE59310308D1 (de) * 1992-06-11 2002-11-21 Merck Patent Gmbh Verfahren und Mittel zum Nachweis von Listerien
US5540926A (en) 1992-09-04 1996-07-30 Bristol-Myers Squibb Company Soluble and its use in B cell stimulation
DE69840326D1 (de) 1997-03-27 2009-01-22 Csl Ltd Steigerung der immunantwort unter verwendung von zielgerichteten molekülen
EP1246643A4 (en) * 1999-10-14 2005-05-11 Jeffery A Ledbetter DNA VACCINES ENCODING ANTIGEN ASSOCIATED WITH CD40-BINDING DOMAIN

Also Published As

Publication number Publication date
EP1932539A2 (en) 2008-06-18
JP2004536783A (ja) 2004-12-09
AU2002230911A1 (en) 2002-07-01
ATE400293T1 (de) 2008-07-15
US7786257B2 (en) 2010-08-31
US20050107585A1 (en) 2005-05-19
EP1404362A4 (en) 2005-06-01
EP1404362A2 (en) 2004-04-07
CA2432767A1 (en) 2002-06-27
WO2002050250A2 (en) 2002-06-27
EP1404362B1 (en) 2008-07-09
WO2002050250A3 (en) 2004-01-08
EP1932539A3 (en) 2008-10-29

Similar Documents

Publication Publication Date Title
ATE400293T1 (de) Signal-1/signal-2-bifunktionelle peptidinhibitoren
SE8703012L (sv) Skyddshandske
ATE536406T1 (de) Neuartiger zytokin-zcytor17-ligand
DE60210022D1 (de) Verbesserte Anordnung von Sensorelementen für einen Fingerabdrucksensor
ATE260389T1 (de) Bausatz mit platten- oder leistenförmigen bauteilen und klammer hierfür
CY1110877T1 (el) Αλλαγη των συγγενειων συνδεσης me fcrn ή των ημιζωων ορου αντισωματων με μεταλλαξιγενεση
ATE388230T1 (de) Neisseria meningitidis antigene und zusammenstellungen
DE69005786D1 (de) Mit Verbrennungsgas betriebenes Eintreibwerkzeug für Befestigungsmittel.
ATE127474T1 (de) Neue peptidasen und isomerasen-inhibitoren.
BG101077A (bg) Пептиди
DK0387231T3 (da) Hidtil ukendte inhibitorer for retroviral protease
DE60320182D1 (de) Elastischer Halter für Finger oder Zehen
DE69732985D1 (de) Verfahren der zelloberflächenaktivierung und -hemmung
ATE382604T1 (de) Aminosäure-derivate als hiv aspartyl-protease- inhibitoren
DK1908772T3 (da) Polypeptider og polynucleinsyrer af phorphorymonas gingivalis
DK524388D0 (da) Forbraending af kul med et fluidiseret forbraendingsleje
ATE147405T1 (de) Analoge von peptrolsubstraten
EP1293567A4 (en) GPR8 LIGAND AND DAFUER ENCODING DNA (02.01.02)
DK431189D0 (da) Peptidaseinhibitorer
DE50102625D1 (de) Verbindungen zur Bestimmung der Aktivität von Phospholipase A2
ATE448308T1 (de) Fructosylamin-oxidase
ATE280229T1 (de) Enterotoxine von shigella flexneri 2a
ES2141105T3 (es) Peptidos ramificados en ensayos para anticuerpos.
DK0994187T3 (da) Renin-aktivt stof omfattende humant prorenin og antistoffer mod prorenin-profragmentet
ATE556233T1 (de) Entwicklungen bei befestigungselementen mit flexiblem träger

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee